Early screening and clinical validation of APO10 and TKTL1 kits in normal population

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200063706

Enrollment

Unknown

Registered

2022-09-15

Start date

2022-09-15

Completion date

Unknown

Last updated

2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early cancer screening

Interventions

None listed

Eligibility

Sex/Gender

All

Age

40 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 40 years old; 2. No history of tumor; 3. No systemic infection or inflammation (including: lung, gastrointestinal tract, pancreas, hepatobiliary system, abdominal cavity, genitourinary system, skin soft tissue, nervous system, endocardium, pericardium, periodontal, blood infection); 4. Routine annual physical examination.

Exclusion criteria

Exclusion criteria: 1. Pregnancy, lactation, mental illness; 2. Organ transplant recipients; 3. HBsAg positive, HCV-Ab positive, HIV-Ab positive, TP-Ab positive.

Design outcomes

Primary

Measure	Time frame
Sensitivity and specificity of Apo10 and TKTL1;	—

Countries

China

Contacts

Public ContactJie Ma

Beijing Hospital

majie1965@163.com+86 18611719182

Outcome results